Buy, Sell or Hold: Motilal Oswal maintains neutral on Lupin; Citi maintains sell on Info Edge

Brokerages offer mixed stock recommendations, with pharma stocks like Lupin and Torrent Pharma seeing target price upgrades despite neutral ratings due to strong quarterly results. Conversely, Citi maintains a sell rating on Info Edge, cutting its target price due to concerns over hiring visibility and valuation de-rating.